Localized Breast Cancer 2026 UPDATE

This week’s episode we welcome back Ethan Zohn, motivational speaker, former professional soccer player, and reality television personality who won Survivor: Africa, the third season of the reality TV series Survivor. He is a 2x cancer survivor and we are so excited to hear his journey. In Part 2, we discuss alternative therapies, advocacies, and more.

This week’s episode we are SO excited to welcome Ethan Zohn, motivational speaker, former professional soccer player, and reality television personality who won Survivor: Africa, the third season of the reality TV series Survivor. He is a 2x cancer survivor and we are so excited to hear his journey. In Part 1, we discuss his cancer journey from diagnosis to survivorship.

This week’s episode will be focusing on how we prepared the days leading up to our exam, wellness tips & a cheat sheet for some of the highest lead topics in lung cancer, breast cancer, vwF, hemoglobinopathies & more.

This week’s episode is a 2026 update focusing on metastatic breast cancer, including the preferred treatment options by receptor (ER/PR/HER2) status + key toxicities of different treatments. 

This week’s episode will be focusing on treatment options for localized breast cancer. We will go all the important details on radiation, as well as therapies based on what the ER/PR/her2 receptor status is.

We are providing 2026 update for our breast cancer episodes, today we cover an introduction on breast cancer screening, prevention. 

This week’s episode we are very excited to welcome back our special guest Dr. Hatim Husain, MD, a medical oncologist and physician-scientist at UC San Diego Moores Cancer Center, whose clinical and research expertise focuses on lung cancer and precision oncology. We further cover the topic of ctDNA, uses, limitations, and future directions.

This week’s episode we are very excited to welcome a special guest Dr. Hatim Husain, MD, a medical oncologist and physician-scientist at UC San Diego Moores Cancer Center, whose clinical and research expertise focuses on lung cancer and precision oncology. We cover the topic of liquid biopsies, ctDNA, NGS panels definitions & current uses.

 This week's episode focuses on metastatic non-small cell lung cancer - the quickly growing and changing systemic therapy landscape, including traditional chemotherapy, immunotherapy, and targeted agents. Since our last recording the number of FDA-approved targeted drugs has  significantly expanded.

This week's episode focuses on early-stage and locally advanced non-small cell lung cancer - staging, pathology, local and systemic therapy. Before we start, the usual caveat: the treatment landscape of NSCLC is changing FAST, which is exciting, but know that the boards run a few years behind. The big shifts since our last episode are the move to 9th-edition TNM staging and the arrival of four different perioperative chemo+immunotherapy regimens. Shout out to Dr. Bharathi Muthusamy for reviewing this episode to keep us current for 2026!